The IMID Forum
Avsnitt

Discussing RA: MACE in RA, data from the "JAK-pot" study, and combination therapy in MTX-IR RA

The IMID Forum
Dela

Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest updates in RA.

In this episode, he discusses two papers: risk of MACE in patients with RA treated with JAKis compared to bDMARDs from the “JAK-pot” study, and the efficacy and safety of zimlovisertib, ritlecitinib and tofacitinib, alone and in combination, in patients with RA and an inadequate response to MTX.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör The Immune-Mediated Inflammatory Disease Forum. Innehållet i podden är skapat av The Immune-Mediated Inflammatory Disease Forum och inte av, eller tillsammans med, Poddtoppen.